Press release
Global Idiopathic Pulmonary Fibrosis (IPF) Market Set for Transformative Growth: Breakthrough Therapies and Rising Prevalence Drive Demand 2025 | Top key players - Genentech Inc., FibroGen Inc., Galapagos NV.
Idiopathic Pulmonary Fibrosis Market
The Idiopathic Pulmonary Fibrosis Market, as analyzed by DataM Intelligence, offers a comprehensive industry overview backed by in-depth insights, historical trends, and key statistics. The report dives deep into market dynamics and competitive strategies, profiling major players along with their product portfolios, pricing models, financial performance, growth initiatives, and regional presence.
Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/idiopathic-pulmonary-fibrosis-market?sz
The Idiopathic Pulmonary Fibrosis (IPF) Market encompasses therapies, diagnostics, and devices for managing IPF, a chronic, progressive lung disease with unknown cause. It includes anti-fibrotic drugs (e.g., pirfenidone, nintedanib), diagnostic tools (HRCT, lung biopsies), and supportive care (oxygen therapy, lung transplants). Market growth is driven by rising prevalence, aging populations, and advancements in treatment options.
Major players in the Idiopathic Pulmonary Fibrosis Market
The prominent players in Idiopathic Pulmonary Fibrosis market research report are: Roche Holdings AG, Boehringer Ingelheim GmbH, Genentech Inc., FibroGen Inc., Galapagos NV, MEDICINOVA INC., Bristol Myers Squibb Company, Biogen Inc., AstraZeneca PLC, and Novartis International AG.
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.
Key Development
May 2023 - Cumberland Pharmaceuticals Inc. received FDA clearance for its Investigational New Drug (IND) application, paving the way for a Phase II clinical trial in Idiopathic Pulmonary Fibrosis (IPF)-the most prevalent progressive fibrosing interstitial lung disease. The FIGHTING FIBROSIS trial will enroll 128 patients across 20+ U.S. medical centers, assessing the potential of Cumberland's novel therapy to address this serious unmet medical need.
May 2023, Simulations Plus, Inc., a leader in pharmaceutical modeling and simulation, launched its integrated pulmonary software and services package. This specialized solution accelerates pulmonary drug development by enhancing predictive modeling, helping pharma companies optimize decision-making and expedite time-to-market for new therapies.
Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/idiopathic-pulmonary-fibrosis-market
Market Segments
By Treatment: Drugs, Nintedanib, Pirfenidone, Oxygen Therapy, Pulmonary rehabilitation, Lung transplant.
By End-User: Hospitals, ASCs, Clinics and Others.
The Idiopathic Pulmonary Fibrosis industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.
Regions Covered:
The global Idiopathic Pulmonary Fibrosis Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Idiopathic Pulmonary Fibrosis (IPF) Market Set for Transformative Growth: Breakthrough Therapies and Rising Prevalence Drive Demand 2025 | Top key players - Genentech Inc., FibroGen Inc., Galapagos NV. here
News-ID: 4059877 • Views: …
More Releases from DataM Intelligence 4Market Research
Global Marine Ingredients Market Surges with Rising Demand for Natural and Susta …
The Global Marine Ingredients Market reached US$ 9.11 billion in 2023 and is expected to reach US$ 15.35 billion by 2031, growing with a CAGR of 6.68% during the forecast period 2024-2031.
The Marine Ingredients Market, as analyzed by DataM Intelligence, offers a comprehensive industry overview backed by in-depth insights, historical trends, and key statistics. The report dives deep into market dynamics and competitive strategies, profiling major players along with their…
Cyber-Physical Systems Market Surges Amid Industry 4.0 Revolution, Paving the Wa …
The Global Cyber Physical Systems Market reached US$137.40 billion in 2024 and is expected to reach US$405.91 billion by 2032, growing with a CAGR of 14.50% during the forecast period 2025-2032.
The Cyber-Physical Systems Market, as analyzed by DataM Intelligence, offers a comprehensive industry overview backed by in-depth insights, historical trends, and key statistics. The report dives deep into market dynamics and competitive strategies, profiling major players along with their product…
AI-Powered Storage Market Set to Surge as Intelligent Infrastructure Transforms …
The Global AI Powered Storage Market reached US$ 29.07 billion in 2024 and is expected to reach US$ 173.82 billion by 2032, growing with a CAGR of 25.05% during the forecast period 2025-2032.
The AI-Powered Storage Market, as analyzed by DataM Intelligence, offers a comprehensive industry overview backed by in-depth insights, historical trends, and key statistics. The report dives deep into market dynamics and competitive strategies, profiling major players along with…
Global Nutrient Recovery Systems Market Accelerates as Demand for Sustainable Wa …
The Global Nutrient Recovery Systems Market reached US$ 5.11 billion in 2024 and is expected to reach US$ 12.20 billion by 2032, growing with a CAGR of 11.5% during the forecast period 2025-2032.
The Nutrient Recovery Systems Market, as analyzed by DataM Intelligence, offers a comprehensive industry overview backed by in-depth insights, historical trends, and key statistics. The report dives deep into market dynamics and competitive strategies, profiling major players along…
More Releases for Pulmonary
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027.
Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC…
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of…
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs
Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated…
Pulmonary Embolism - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Pulmonary Embolism - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Embolism - Pipeline Review, H2 2017, provides an overview of the Pulmonary Embolism (Cardiovascular) pipeline landscape.
Pulmonary embolism is the sudden blockage of a major blood vessel (artery) in the lung, usually by a blood…
Pulmonary Drugs 2024 Market Research Report
Global Pulmonary Drugs Market: Snapshot
The global pulmonary drugs market has been the key area of focus and the most crucial market for the healthcare industry in the last couple of years. However, the market is expected to witness a significant decline over the forecast period with a -6.3% CAGR from 2016 to 2024. The market is anticipated to fall to US$28,082.1 mn from a valuation of US$48,039.7 mn in…
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments…
